Effect of Secreted Frizzled-Related Protein 5 in Mice with Heart Failure

被引:0
|
作者
Hong, Pan [1 ]
Wang, Lijie [1 ]
Wang, Hongchao [1 ]
Shi, Min [2 ]
Guo, Bingyan [1 ,2 ]
机构
[1] Second Hosp Hebei Med Univ, Dept Cardiol, Shijiazhuang 050017, Peoples R China
[2] Hebei Key Lab Lab Med, Shijiazhuang 050017, Peoples R China
基金
中国国家自然科学基金;
关键词
WNT-INHIBITORS; ROLES; SFRP5; EXPRESSION;
D O I
10.1155/2022/1606212
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Although some progress has been made in its treatment, heart failure is still one of the most important health problems that endanger public health. This study aims to explore the myocardial protective effect of secreted frizzled-related protein 5 (SFRP5) on mice with heart failure. The mouse model of heart failure was established by using the isoproterenol (ISO) hydrochloride gradient modeling method. The treatment group was injected with 0.02 mg/kg/24 h SFRP5 recombinant protein intraperitoneally 30 minutes after the injection of isoproterenol, and the ISO + phosphate-buffered saline (PBS) group was injected with the same amount of PBS. After intraperitoneal injection of SFRP5 recombinant protein in mice with heart failure, the inflammatory response was reduced, and the left ventricular systolic and diastolic function of heart failure mice and the pathological structure of the myocardial tissue were improved. Compared with the ISO group, the expression level of SFRP5 protein in the ISO + SFRP5 group was increased significantly, the expression levels of Wnt5a and JNK protein were decreased markedly, and the enzyme activities of SOD and GSH-Px in the serum were observably increased, but they were lower than those parameters in the normal group. The SFRP5 recombinant protein has a protective effect on isoproterenol-induced heart failure in mice. The mechanism of action may be related to inhibiting the Wnt5A/JNK signaling pathway and reducing oxidative stress and inflammation. SFRP5 may be one of the therapeutic targets of heart failure.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Secreted Frizzled-Related Protein 2 and Extracellular Volume Fraction in Patients with Heart Failure
    Yang, Shaomin
    Chen, Haixiong
    Tan, Kuan
    Cai, Fusheng
    Du, Yongxing
    Lv, Weibiao
    Hu, Qiugen
    Hu, Yunzhao
    Huang, Yuli
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [2] Prognostic Value of Secreted Frizzled-Related Protein 5 in Heart Failure Patients With and Without Type 2 Diabetes Mellitus
    Wu, Jiandi
    Zheng, Haoxiao
    Liu, Xinyue
    Chen, Peisong
    Zhang, Yunlong
    Luo, Jianjin
    Kuang, Jian
    Li, Jingwei
    Yang, Yu
    Ma, Tianyi
    Yang, Yanhua
    Huang, Xiaohui
    Liang, Guoquan
    Liang, Donglian
    Hu, Yunzhao
    Wu, Jason H. Y.
    Arnott, Clare
    Mai, Weiyi
    Huang, Yuli
    [J]. CIRCULATION-HEART FAILURE, 2020, 13 (09) : E007054
  • [3] Inhibition of secreted frizzled-related protein 5 improves glucose metabolism
    Rulifson, Ingrid C.
    Majeti, Jiangwen Z.
    Xiong, Yumei
    Hamburger, Agi
    Lee, Ki Jeong
    Miao, Li
    Lu, Mei
    Gardner, Jonitha
    Gong, Yan
    Wu, Hai
    Case, Ryan
    Yeh, Wen-Chen
    Richards, William G.
    Baribault, Helene
    Li, Yang
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2014, 307 (12): : E1144 - E1152
  • [4] Action and Mechanism of Secreted Frizzled-Related Protein 5 in Cardiomyocyte Hypertrophy
    Xin, Jin
    Guo, Bingyan
    Li, Yongjun
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C43 - C43
  • [5] The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure
    Askevold, E. T.
    Aukrust, P.
    Nymo, S. H.
    Lunde, I. G.
    Kaasboll, O. J.
    Aakhus, S.
    Florholmen, G.
    Ohm, I. K.
    Strand, M. E.
    Attramadal, H.
    Fiane, A.
    Dahl, C. P.
    Finsen, A. V.
    Vinge, L. E.
    Christensen, G.
    Yndestad, A.
    Gullestad, L.
    Latini, R.
    Masson, S.
    Tavazzi, L.
    Ueland, T.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2014, 275 (06) : 621 - 630
  • [6] Secreted Frizzled-Related Protein 4 An Angiogenesis Inhibitor
    Muley, Ajit
    Majumder, Syamantak
    Kolluru, Gopi Krishna
    Parkinson, Steve
    Viola, Helena
    Hool, Livia
    Arfuso, Frank
    Ganss, Ruth
    Dharmarajan, Arun
    Chatterjee, Suvro
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1505 - 1516
  • [7] Early Pregnancy Serum Concentration of Secreted Frizzled-Related Protein 4, Secreted Frizzled-Related Protein 5, and Chemerin in Obese Women Who Develop Gestational Diabetes Mellitus
    Beernink, Rik H. J.
    Schuitemaker, Joost H. N.
    Faas, Marijke M.
    Poston, Lucilla
    White, Sara L.
    [J]. DIABETOLOGY, 2022, 3 (01): : 258 - 265
  • [8] Secreted Frizzled-related Protein 5 Diminishes Cardiac Inflammation and Protects the Heart from Ischemia/Reperfusion Injury
    Nakamura, Kazuto
    Sano, Soichi
    Fuster, Jose J.
    Kikuchi, Ryosuke
    Shimizu, Ippei
    Ohshima, Kousei
    Katanasaka, Yasufumi
    Ouchi, Noriyuki
    Walsh, Kenneth
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (06) : 2566 - 2575
  • [9] Effects of secreted frizzled-related protein 3 on osteoblasts in vitro
    Chung, YS
    Baylink, DJ
    Srivastava, AK
    Amaar, Y
    Tapia, B
    Kasukawa, Y
    Mohan, S
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1395 - 1402
  • [10] Fritz: A secreted frizzled-related protein that inhibits Wnt activity
    Mayr, T
    Deutsch, U
    Kuhl, M
    Drexler, HCA
    Lottspeich, F
    Deutzmann, R
    Wedlich, D
    Risau, W
    [J]. MECHANISMS OF DEVELOPMENT, 1997, 63 (01) : 109 - 125